Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases.

Eichhorst A, Daniel C, Rzepka R, Sehnert B, Nimmerjahn F, Voll RE, Chevalier N.

Int J Mol Sci. 2019 Jul 1;20(13). pii: E3234. doi: 10.3390/ijms20133234.

2.

Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.

Jülich M, Kanne AM, Sehnert B, Budweiser S, Voll RE, Kollert F.

Clin Rheumatol. 2018 Sep;37(9):2361-2366. doi: 10.1007/s10067-018-4159-2. Epub 2018 Jun 1.

PMID:
29858711
3.

Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome.

Kanne AM, Jülich M, Mahmutovic A, Tröster I, Sehnert B, Urbonaviciute V, Voll RE, Kollert F.

Arthritis Care Res (Hoboken). 2018 Jun;70(6):944-948. doi: 10.1002/acr.23420. Epub 2018 Apr 23.

4.

The sneaking ligand approach for cell type-specific modulation of intracellular signalling pathways.

Sehnert B, Burkhardt H, Finzel S, Dübel S, Voll RE.

Clin Immunol. 2018 Jan;186:14-20. doi: 10.1016/j.clim.2017.08.018. Epub 2017 Sep 1.

PMID:
28867254
5.

Sneaking-ligand fusion proteins attenuate serum transfer arthritis by endothelium-targeted NF-κB inhibition.

Sehnert B, Burkhardt H, May MJ, Zwerina J, Voll RE.

Methods Mol Biol. 2015;1280:579-91. doi: 10.1007/978-1-4939-2422-6_34.

PMID:
25736773
6.

The "sneaking-ligand" approach: cell-type specific inhibition of the classical NF-κB pathway.

Sehnert B, Burkhardt H, Dübel S, Voll RE.

Methods Mol Biol. 2015;1280:559-78. doi: 10.1007/978-1-4939-2422-6_33.

PMID:
25736772
7.

Rsk2 controls synovial fibroblast hyperplasia and the course of arthritis.

Derer A, Böhm C, Grötsch B, Grün JR, Grützkau A, Stock M, Böhm S, Sehnert B, Gaipl U, Schett G, Hueber AJ, David JP.

Ann Rheum Dis. 2016 Feb;75(2):413-21. doi: 10.1136/annrheumdis-2014-205618. Epub 2014 Nov 20.

PMID:
25414238
8.

Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.

Toh ML, Bonnefoy JY, Accart N, Cochin S, Pohle S, Haegel H, De Meyer M, Zemmour C, Preville X, Guillen C, Thioudellet C, Ancian P, Lux A, Sehnert B, Nimmerjahn F, Voll RE, Schett G.

Arthritis Rheumatol. 2014 Nov;66(11):2989-3000. doi: 10.1002/art.38624.

9.

NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.

Sehnert B, Burkhardt H, Wessels JT, Schröder A, May MJ, Vestweber D, Zwerina J, Warnatz K, Nimmerjahn F, Schett G, Dübel S, Voll RE.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16556-61. doi: 10.1073/pnas.1218219110. Epub 2013 Sep 23.

10.

Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis.

Binder M, Christoph S, Sehnert B, Uhl M, Peter HH, Voll RE, Warnatz K, Kollert F.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):772-5. Epub 2012 Oct 17.

PMID:
22935225
11.

Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.

Kollert F, Christoph S, Probst C, Budweiser S, Bannert B, Binder M, Sehnert B, Voll RE, Warnatz K, Zissel G, Walker UA, Prasse A, Saalbach A.

Arthritis Care Res (Hoboken). 2013 Feb;65(2):281-7. doi: 10.1002/acr.21799.

12.

Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.

Rau TT, Rogler A, Frischauf M, Jung A, Konturek PC, Dimmler A, Faller G, Sehnert B, El-Rifai W, Hartmann A, Voll RE, Schneider-Stock R.

Am J Pathol. 2012 Aug;181(2):487-98. doi: 10.1016/j.ajpath.2012.04.028. Epub 2012 Jun 27.

13.

Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus.

Weber CK, Haslbeck M, Englbrecht M, Sehnert B, Mielenz D, Graef D, Distler JH, Mueller RB, Burkhardt H, Schett G, Voll RE, Fürnrohr BG.

Rheumatology (Oxford). 2010 Dec;49(12):2255-63. doi: 10.1093/rheumatology/keq272. Epub 2010 Aug 17.

PMID:
20716673
14.

Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.

Merky P, Batsalova T, Bockermann R, Dzhambazov B, Sehnert B, Burkhardt H, Bäcklund J.

Arthritis Res Ther. 2010;12(4):R155. doi: 10.1186/ar3108. Epub 2010 Aug 3.

15.

Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis.

Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engström A, Serre G, Burkhardt H, Thunnissen MM, Holmdahl R.

J Exp Med. 2009 Feb 16;206(2):449-62. doi: 10.1084/jem.20081862. Epub 2009 Feb 9.

16.

Collagen type II is recognized by a pathogenic antibody through germline encoded structures.

Böiers U, Lanig H, Sehnert B, Holmdahl R, Burkhardt H.

Eur J Immunol. 2008 Oct;38(10):2784-95. doi: 10.1002/eji.200838238.

17.

The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.

Uysal H, Sehnert B, Nandakumar KS, Böiers U, Burkhardt H, Holmdahl R, Thunnissen MM.

Mol Immunol. 2008 Apr;45(8):2196-204. doi: 10.1016/j.molimm.2007.12.005. Epub 2008 Feb 1.

PMID:
18241923
18.

Interaction of histones with phospholipids--implications for the exposure of histones on apoptotic cells.

Fürnrohr BG, Groer GJ, Sehnert B, Herrmann M, Voll RE.

Autoimmunity. 2007 Jun;40(4):322-6.

PMID:
17516219
19.

Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium.

Sehnert B, Gierer P, Ibrahim S, Kühl A, Voll R, Nandakumar KS, Holmdahl R, Hallmann R, Vollmar B, Burkhardt H.

Arthritis Res Ther. 2006;8(4):R95.

20.

Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.

Burkhardt H, Sehnert B, Bockermann R, Engström A, Kalden JR, Holmdahl R.

Eur J Immunol. 2005 May;35(5):1643-52.

Supplemental Content

Loading ...
Support Center